Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-θ Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-κB, OCT-1, or NF-AT
Payvandi, Faribourz, Wu, Lei, Naziruddin, Syedah D., Haley, Maura, Parton, Anastasia, Schafer, Peter H., Chen, Roger S., Muller, George W., Hughes, Christopher C.W., Stirling, David I.
Published in Journal of interferon & cytokine research (01.10.2005)
Published in Journal of interferon & cytokine research (01.10.2005)
Get full text
Journal Article
Immunomodulatory Drugs (IMiDs) Increase the Production of IL-2 from Stimulated T Cells by Increasing PKC-[theta] Activation and Enhancing the DNA-Binding Activity of AP-1 but Not NF-[kappa]B, OCT-1, or NF-AT
Payvandi, Faribourz, Wu, Lei, Naziruddin, Syedah D, Haley, Maura, Parton, Anastasia, Schafer, Peter H, Chen, Roger S, Muller, George W, Christopher C.W. Hughes, Stirling, David I
Published in Journal of interferon & cytokine research (01.10.2005)
Published in Journal of interferon & cytokine research (01.10.2005)
Get full text
Journal Article
Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT
Payvandi, Faribourz, Wu, Lei, Naziruddin, Syedah D, Haley, Maura, Parton, Anastasia, Schafer, Peter H, Chen, Roger S, Muller, George W, Hughes, Christopher C W, Stirling, David I
Published in Journal of interferon & cytokine research (01.10.2005)
Get full text
Published in Journal of interferon & cytokine research (01.10.2005)
Journal Article